Adherence to the 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline on the Use of Oral Anticoagulant Agents in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study.
Ayman J HammoudehYousef Saleh KhaderNazih KadriEyas Al-MousaYahya BadainehLaith HabahbehRamzi A TabbalatHesham JanabiImad A AlhaddadPublished in: International journal of vascular medicine (2021)
The current status of the utilization of OACs in Middle Eastern AF patients appears to be promising and is consistent with the 2019 focused update of the 2014 AHA/ACC/HRS guideline. This trial is registered with NCT03917992.
Keyphrases
- atrial fibrillation
- end stage renal disease
- current status
- south africa
- ejection fraction
- chronic kidney disease
- newly diagnosed
- catheter ablation
- heart failure
- clinical trial
- study protocol
- oral anticoagulants
- venous thromboembolism
- peritoneal dialysis
- prognostic factors
- direct oral anticoagulants
- left atrial appendage
- randomized controlled trial
- phase iii
- patient reported outcomes
- adipose tissue